GMP viral vectors

ABL Europe is 100 % dedicated to viral vectors. ABL Europe has completed projects from process and analytical development using a variety of manufacturing technologies resulting in the delivery of over 100 DS lots & 200 DP of clinical trial materials (Phase 1 to 3).

Virus Types:

Vaccinia, Adenovirus, MVA, Arenavirus, Measles, VLPs

AAV platform in development

Viral vectors for: oncolytic immunotherapy, infectious disease and genetic disorders

Cell Types:

GMP production in: HEK293, HeLa, VERO, A549, CEFs

Adherent (< 60 m2). Suspension (< 500 L) in stirred SUB